Company intelligence / Profile preview

Vitality Biotech

Kyiv, Kyiv, Ukrainepowerofvitality.com ↗

Ownership: Private
Development stage: Commercial

Overview

Vitality Biotech supplies high-quality human mesenchymal stem cells from various tissue sources and exosomes to support global biomedical research. All biospecimens are ethically sourced and compliant with international standards. The company does not have clinical results as it does not develop therapeutics directly.

Modalities: Cell therapy (Human Mesenchymal Stem Cells)Exosome-based therapy
Industry: Non-Drug Biotech

Drug pipeline

4 assets

RSVpreF

Registration

Indications: Respiratory syncytial virus

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Vitality Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitality Biotech.

Explore the full profile